MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas

Zsófia Tömböl, Katalin Éder, Attila Kovács, Peter M. Szabó, J. Kulka, István Likó, A. Zalatnai, Gergely Rácz, Miklós Tóth, A. Patócs, A. Falus, K. Rácz, P. Igaz

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

MicroRNAs are involved in the pathogenesis of several tumors, however, there have been no data on microRNA expression in pheochromocytomas to date. The objective of our study was to perform microRNA expression profiling in sporadic and hereditary benign, and recurring adrenomedullary tumors. Furthermore, the applicability of formalin-fixed paraffin-embedded tissue samples for the analysis of microRNA expression in pheochromocytomas was examined. MicroRNA expression data of three matched frozen and formalin-fixed paraffin-embedded samples were correlated. A total of 21 formalin-fixed paraffin-embedded samples (sporadic benign, multiple endocrine neoplasia 2, von Hippel-Lindau disease, sporadic recurring) were subjected to microRNA expression profiling using microarrays. MicroRNAs with significant differences in expression were validated and sample sizes were extended including tumors from neurofibromatosis type 1 patients by real-time quantitative reverse-transcription PCR (n33). MicroRNA target prediction was carried out by TargetScan and MicroCosm Targets. Pathway analysis of targets was performed by Ingenuity Pathway Analysis and DIANA mirPath. Furthermore, microRNA expression profiles of a malignant pheochromocytoma and a pair of primary and recurrent tumors were studied by TaqMan Human MicroRNA Cards. MicroRNA expression correlated well between frozen and formalin-fixed paraffin-embedded samples (70-92%). Microarray analysis revealed 16 significantly differentially expressed microRNAs. Five of these were validated by real-time RT-PCR. miR-139-3p, miR-541 and miR-765 were significantly differentially expressed between sporadic benign and von Hippel-Lindau-related pheochromocytomas. Significantly higher expression of miR-885-5p and miR-1225-3p was found in multiple endocrine neoplasia type 2 and sporadic recurring pheochromocytomas, respectively. Pathway analysis revealed the possible involvement of Notch- and G-protein-coupled receptor signaling in tumor recurrence. MicroRNA expression profiles in the primary recurrent and recurring malignant comparisons have been similar. In conclusion, we have proved that formalin-fixed paraffin-embedded samples can be used for the analysis of microRNA expression in pheochromocytomas. MicroRNA expression patterns differ between various sporadic, hereditary and recurring tumors and miR-1225-3p may be useful for identifying recurring pheochromocytomas.

Original languageEnglish
Pages (from-to)1583-1595
Number of pages13
JournalModern Pathology
Volume23
Issue number12
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Pheochromocytoma
MicroRNAs
Paraffin
Formaldehyde
Neoplasms
Notch Receptors
Multiple Endocrine Neoplasia Type 2a
Multiple Endocrine Neoplasia
von Hippel-Lindau Disease
Neurofibromatosis 1
Microarray Analysis
G-Protein-Coupled Receptors
Sample Size
Reverse Transcription
Real-Time Polymerase Chain Reaction

Keywords

  • formalin-fixed paraffin-embedded
  • microRNA
  • multiple endocrine neoplasia type 2
  • pheochromocytoma
  • recurring
  • von Hippel-Lindau disease

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. / Tömböl, Zsófia; Éder, Katalin; Kovács, Attila; Szabó, Peter M.; Kulka, J.; Likó, István; Zalatnai, A.; Rácz, Gergely; Tóth, Miklós; Patócs, A.; Falus, A.; Rácz, K.; Igaz, P.

In: Modern Pathology, Vol. 23, No. 12, 12.2010, p. 1583-1595.

Research output: Contribution to journalArticle

Tömböl, Zsófia ; Éder, Katalin ; Kovács, Attila ; Szabó, Peter M. ; Kulka, J. ; Likó, István ; Zalatnai, A. ; Rácz, Gergely ; Tóth, Miklós ; Patócs, A. ; Falus, A. ; Rácz, K. ; Igaz, P. / MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. In: Modern Pathology. 2010 ; Vol. 23, No. 12. pp. 1583-1595.
@article{5b6592d39d194050844ace64b40012b1,
title = "MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas",
abstract = "MicroRNAs are involved in the pathogenesis of several tumors, however, there have been no data on microRNA expression in pheochromocytomas to date. The objective of our study was to perform microRNA expression profiling in sporadic and hereditary benign, and recurring adrenomedullary tumors. Furthermore, the applicability of formalin-fixed paraffin-embedded tissue samples for the analysis of microRNA expression in pheochromocytomas was examined. MicroRNA expression data of three matched frozen and formalin-fixed paraffin-embedded samples were correlated. A total of 21 formalin-fixed paraffin-embedded samples (sporadic benign, multiple endocrine neoplasia 2, von Hippel-Lindau disease, sporadic recurring) were subjected to microRNA expression profiling using microarrays. MicroRNAs with significant differences in expression were validated and sample sizes were extended including tumors from neurofibromatosis type 1 patients by real-time quantitative reverse-transcription PCR (n33). MicroRNA target prediction was carried out by TargetScan and MicroCosm Targets. Pathway analysis of targets was performed by Ingenuity Pathway Analysis and DIANA mirPath. Furthermore, microRNA expression profiles of a malignant pheochromocytoma and a pair of primary and recurrent tumors were studied by TaqMan Human MicroRNA Cards. MicroRNA expression correlated well between frozen and formalin-fixed paraffin-embedded samples (70-92{\%}). Microarray analysis revealed 16 significantly differentially expressed microRNAs. Five of these were validated by real-time RT-PCR. miR-139-3p, miR-541 and miR-765 were significantly differentially expressed between sporadic benign and von Hippel-Lindau-related pheochromocytomas. Significantly higher expression of miR-885-5p and miR-1225-3p was found in multiple endocrine neoplasia type 2 and sporadic recurring pheochromocytomas, respectively. Pathway analysis revealed the possible involvement of Notch- and G-protein-coupled receptor signaling in tumor recurrence. MicroRNA expression profiles in the primary recurrent and recurring malignant comparisons have been similar. In conclusion, we have proved that formalin-fixed paraffin-embedded samples can be used for the analysis of microRNA expression in pheochromocytomas. MicroRNA expression patterns differ between various sporadic, hereditary and recurring tumors and miR-1225-3p may be useful for identifying recurring pheochromocytomas.",
keywords = "formalin-fixed paraffin-embedded, microRNA, multiple endocrine neoplasia type 2, pheochromocytoma, recurring, von Hippel-Lindau disease",
author = "Zs{\'o}fia T{\"o}mb{\"o}l and Katalin {\'E}der and Attila Kov{\'a}cs and Szab{\'o}, {Peter M.} and J. Kulka and Istv{\'a}n Lik{\'o} and A. Zalatnai and Gergely R{\'a}cz and Mikl{\'o}s T{\'o}th and A. Pat{\'o}cs and A. Falus and K. R{\'a}cz and P. Igaz",
year = "2010",
month = "12",
doi = "10.1038/modpathol.2010.164",
language = "English",
volume = "23",
pages = "1583--1595",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas

AU - Tömböl, Zsófia

AU - Éder, Katalin

AU - Kovács, Attila

AU - Szabó, Peter M.

AU - Kulka, J.

AU - Likó, István

AU - Zalatnai, A.

AU - Rácz, Gergely

AU - Tóth, Miklós

AU - Patócs, A.

AU - Falus, A.

AU - Rácz, K.

AU - Igaz, P.

PY - 2010/12

Y1 - 2010/12

N2 - MicroRNAs are involved in the pathogenesis of several tumors, however, there have been no data on microRNA expression in pheochromocytomas to date. The objective of our study was to perform microRNA expression profiling in sporadic and hereditary benign, and recurring adrenomedullary tumors. Furthermore, the applicability of formalin-fixed paraffin-embedded tissue samples for the analysis of microRNA expression in pheochromocytomas was examined. MicroRNA expression data of three matched frozen and formalin-fixed paraffin-embedded samples were correlated. A total of 21 formalin-fixed paraffin-embedded samples (sporadic benign, multiple endocrine neoplasia 2, von Hippel-Lindau disease, sporadic recurring) were subjected to microRNA expression profiling using microarrays. MicroRNAs with significant differences in expression were validated and sample sizes were extended including tumors from neurofibromatosis type 1 patients by real-time quantitative reverse-transcription PCR (n33). MicroRNA target prediction was carried out by TargetScan and MicroCosm Targets. Pathway analysis of targets was performed by Ingenuity Pathway Analysis and DIANA mirPath. Furthermore, microRNA expression profiles of a malignant pheochromocytoma and a pair of primary and recurrent tumors were studied by TaqMan Human MicroRNA Cards. MicroRNA expression correlated well between frozen and formalin-fixed paraffin-embedded samples (70-92%). Microarray analysis revealed 16 significantly differentially expressed microRNAs. Five of these were validated by real-time RT-PCR. miR-139-3p, miR-541 and miR-765 were significantly differentially expressed between sporadic benign and von Hippel-Lindau-related pheochromocytomas. Significantly higher expression of miR-885-5p and miR-1225-3p was found in multiple endocrine neoplasia type 2 and sporadic recurring pheochromocytomas, respectively. Pathway analysis revealed the possible involvement of Notch- and G-protein-coupled receptor signaling in tumor recurrence. MicroRNA expression profiles in the primary recurrent and recurring malignant comparisons have been similar. In conclusion, we have proved that formalin-fixed paraffin-embedded samples can be used for the analysis of microRNA expression in pheochromocytomas. MicroRNA expression patterns differ between various sporadic, hereditary and recurring tumors and miR-1225-3p may be useful for identifying recurring pheochromocytomas.

AB - MicroRNAs are involved in the pathogenesis of several tumors, however, there have been no data on microRNA expression in pheochromocytomas to date. The objective of our study was to perform microRNA expression profiling in sporadic and hereditary benign, and recurring adrenomedullary tumors. Furthermore, the applicability of formalin-fixed paraffin-embedded tissue samples for the analysis of microRNA expression in pheochromocytomas was examined. MicroRNA expression data of three matched frozen and formalin-fixed paraffin-embedded samples were correlated. A total of 21 formalin-fixed paraffin-embedded samples (sporadic benign, multiple endocrine neoplasia 2, von Hippel-Lindau disease, sporadic recurring) were subjected to microRNA expression profiling using microarrays. MicroRNAs with significant differences in expression were validated and sample sizes were extended including tumors from neurofibromatosis type 1 patients by real-time quantitative reverse-transcription PCR (n33). MicroRNA target prediction was carried out by TargetScan and MicroCosm Targets. Pathway analysis of targets was performed by Ingenuity Pathway Analysis and DIANA mirPath. Furthermore, microRNA expression profiles of a malignant pheochromocytoma and a pair of primary and recurrent tumors were studied by TaqMan Human MicroRNA Cards. MicroRNA expression correlated well between frozen and formalin-fixed paraffin-embedded samples (70-92%). Microarray analysis revealed 16 significantly differentially expressed microRNAs. Five of these were validated by real-time RT-PCR. miR-139-3p, miR-541 and miR-765 were significantly differentially expressed between sporadic benign and von Hippel-Lindau-related pheochromocytomas. Significantly higher expression of miR-885-5p and miR-1225-3p was found in multiple endocrine neoplasia type 2 and sporadic recurring pheochromocytomas, respectively. Pathway analysis revealed the possible involvement of Notch- and G-protein-coupled receptor signaling in tumor recurrence. MicroRNA expression profiles in the primary recurrent and recurring malignant comparisons have been similar. In conclusion, we have proved that formalin-fixed paraffin-embedded samples can be used for the analysis of microRNA expression in pheochromocytomas. MicroRNA expression patterns differ between various sporadic, hereditary and recurring tumors and miR-1225-3p may be useful for identifying recurring pheochromocytomas.

KW - formalin-fixed paraffin-embedded

KW - microRNA

KW - multiple endocrine neoplasia type 2

KW - pheochromocytoma

KW - recurring

KW - von Hippel-Lindau disease

UR - http://www.scopus.com/inward/record.url?scp=78649718773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649718773&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2010.164

DO - 10.1038/modpathol.2010.164

M3 - Article

VL - 23

SP - 1583

EP - 1595

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 12

ER -